Stock SGTI SHENGTAI PHARMACEUTICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Shengtai Pharmaceutical, Inc.

Equities

SGTI

US8232142005

Market Closed - OTC Markets
Other stock markets
 01:10:00 12/12/2023 GMT 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Shengtai Pharmaceutical, Inc. -.--% -.--%
2013 Qingtai Liu, Chairman and Chief Executive Officer of Shengtai Pharmaceutical Inc. cancelled the acquisition of the remaining 59.5% stake in Shengtai Pharmaceutical Inc. from Pope Investments LLC, a fund of Pope Asset Management, LLC and other investors. CI
2013 Shengtai Pharmaceutical Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2013 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Generic Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SHENGTAI PHARMACEUTICAL, INC. Stock Shengtai Pharmaceutical, Inc.
 9 - - - - -
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
 42.79B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
 22.81B
SANDOZ GROUP AG Stock Sandoz Group AG
 15.04B
CIPLA LIMITED Stock Cipla Limited
 14.49B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
 12.65B
  1. Stock Market
  2. Equities
  3. SGTI Stock
  4. Charts Shengtai Pharmaceutical, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW